Caresyntax Raises $180M for AI Surgery Platform

Team S · 2024-08-19T09:13:37.000Z

Berlin-based Caresyntax has recently secured a substantial $180 million Series C extension to enhance its AI-driven data platform for surgeries. This funding round comprises $80 million in equity and $100 million in debt, marking a significant milestone for the company. This latest investment follows their previous $130 million Series C raised in 2021, bringing their total equity funding to an impressive $220 million. The new capital will be instrumental in scaling customer adoption in the US and EMEA regions, developing advanced AI applications, and financing potential mergers and acquisitions. Caresyntax aims to create an "Android" platform for surgery, leveraging AI to analyze data collected before, during, and after surgical procedures. This technology is designed to improve patient outcomes, identify risks, and reduce costs associated with surgeries. One of the standout features of Caresyntax’s platform is its ability to integrate with any operating room technology, providing real-time insights and streamlining workflows. Given that operations account for 30% of healthcare costs, this presents a significant opportunity for the company to make a meaningful impact in the healthcare sector. Founded in Germany in 2013 and expanding to San Francisco in 2019, Caresyntax’s platform is currently utilized in 3,000 operating rooms worldwide, contributing to over 3 million surgeries annually. The recent funding underscores a growing trend of substantial investments in European medtech startups focused on operating theatre technologies. Notable investors in this round include Symbiotic Capital, MTIP AG, and BlackRock Innovation Capital, among others.

Member Login Get Access

Caresyntax Raises $180M for AI Surgery Platform | Newnex